Crohn’s Disease Therapeutics Market Advances as Biologic Innovation Reshapes Inflammatory Bowel
Key Highlights The Crohn’s Disease Therapeutics Market was valued at USD 9.99 billion in 2023 and is expected to reach USD 14.89 billion by 2030, growing at a CAGR of 5.8% during 2024–2030. Increasing demand for advanced therapies is supporting market expansion as healthcare providers focus on disease control and patient outcomes. The Biologics segment … Read more